Similar articles

• Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.

  O'Shaughnessy J. O'Shaughnessy J. Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):15-21. Oncology (Williston Park). 2003. PMID: 14768400 Review.
• Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.

  Vassilomanolakis M, Koumakis G, Demiri M, Missitzis J, Barbounis V, Efremidis AP. Vassilomanolakis M, et al. Cancer Invest. 2003;21(4):497-504. doi: 10.1081/cnv-120022358. Cancer Invest. 2003. PMID: 14533438 Clinical Trial.
• Treatment options for patients with pretreated metastatic breast cancer.

  Heinemann V. Heinemann V. Lancet Oncol. 2007 Mar;8(3):187-9. doi: 10.1016/S1470-2045(07)70052-9. Lancet Oncol. 2007. PMID: 17329187 No abstract available.
• The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.

  Morabito A, Filippelli G, Palmeri S, Cascinu S, Ferraù F, Zagonel V, Gattuso D, Catalano V, Capaccetti B, Franciosi V, Accurso V, Scinto F, Gasparini G. Morabito A, et al. Breast Cancer Res Treat. 2003 Mar;78(1):29-36. doi: 10.1023/a:1022197109592. Breast Cancer Res Treat. 2003. PMID: 12611454 Clinical Trial.
• [Gemcitabine and breast cancer].

  Besse B, Spano JP. Besse B, et al. Bull Cancer. 2002 Aug;89 Spec No:S107-14. Bull Cancer. 2002. PMID: 12449040 Review. French.